Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1

Endocrinology

Volumn 152, Issue 6, 2011, Pages 2266-2277

  Suda, Noriko ^a   Shibata, Hirotaka ^a   Kurihara, Isao ^a   Ikeda, Yayoi ^b   Kobayashi, Sakiko ^a   Yokota, Kenichi ^a   Murai Takeda, Ayano ^a   Nakagawa, Ken ^a   Oya, Mototsugu ^a   Murai, Masaru ^a   Rainey, William E ^c   Saruta, Takao ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOCHROME P450; CYTOCHROME P450 17; CYTOCHROME P450 CYP11B1; MESSENGER RNA; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT1; PROTEIN UBC9; SMALL INTERFERING RNA; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG;

ACTH SECRETING ADENOMA; ADRENAL CORTEX; ADRENAL CORTEX CELL; ADULT; ALDOSTERONE PRODUCING ADENOMA; ARTICLE; CELL NUCLEUS; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTISOL PRODUCING ADENOMA; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MUTANT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; STEROIDOGENESIS; SUMOYLATION; TRANSACTIVATION; TRANSCRIPTION INITIATION; WESTERN BLOTTING; WILD TYPE;

ADRENAL CORTEX; ALDOSTERONE SYNTHASE; CELL LINE, TUMOR; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN INHIBITORS OF ACTIVATED STAT; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; STEROIDOGENIC FACTOR 1; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; UBIQUITIN-CONJUGATING ENZYMES;

EID: 79956329911     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1232     Document Type: Article

References (58)

1. Morohashi K, Honda S, Inomata Y, Handa H, Omura T 1992 A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. J Biol Chem 267:17913-17919
2. Rice DA, Mouw AR, Bogerd AM, Parker KL 1991 A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 5:1552-1561
3. Achermann JC, Ozisik G, Ito M, Orun UA, Harmanci K, Gurakan B, Jameson JL 2002 Gonadal determination and adrenal development are regulated by the orphan nuclear receptor steroidogenic factor-1, in a dose-dependent manner. J Clin Endocrinol Metab 87: 1829-1833 (Pubitemid 34615276)
4. Bland ML, Fowkes RC, Ingraham HA 2004 Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol Endocrinol 18:941-952 (Pubitemid 38429483)
5. Fatchiyah, Zubair M, Shima Y, Oka S, Ishihara S, Fukui-Katoh Y, Morohashi K 2006 Differential gene dosage effects of Ad4BP/SF-1 on target tissue development. Biochem Biophys Res Commun 341: 1036-1045 (Pubitemid 43221770)
6. Hammer GD, Parker KL, Schimmer BP 2005 Minireview: transcriptional regulation of adrenocortical development. Endocrinology 146:1018-1024 (Pubitemid 40289290)
7. Ikeda Y, Shen WH, Ingraham HA, Parker KL 1994 Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 8:654-662 (Pubitemid 24174502)
8. Morohashi KI 1999 Gonadal and extragonadal functions of Ad4BP/ SF-1: developmental aspects. Trends Endocrinol Metab 10:169-173
9. Schimmer BP, White PC 2010 Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. Mol Endocrinol 24:1322-1337
10. Zhao L, Bakke M, Hanley NA, Majdic G, Stallings NR, Jeyasuria P, Parker KL 2004 Tissue-specific knockouts of steroidogenic factor 1. Mol Cell Endocrinol 215:89-94 (Pubitemid 38333246)
11. Luo X, Ikeda Y, Parker KL 1994 A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77:481-490 (Pubitemid 24153989)
12. Ikeda Y, Luo X, Abbud R, Nilson JH, Parker KL 1995 The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 9:478-486
13. Tran PV, Lee MB, Marín O, Xu B, Jones KR, Reichardt LF, Rubenstein JR, Ingraham HA 2003 Requirement of the orphan nuclear receptor SF-1 in terminal differentiation of ventromedial hypothalamic neurons. Mol Cell Neurosci 22:441-453 (Pubitemid 36513568)
14. Zhao L, Bakke M, Parker KL 2001 Pituitary-specific knockout of steroidogenic factor 1. Mol Cell Endocrinol 185:27-32 (Pubitemid 33103950)
15. Desclozeaux M, Krylova IN, Horn F, Fletterick RJ, Ingraham HA 2002 Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol Cell Biol 22:7193-7203
16. Sewer MB, Waterman MR 2003 CAMP-dependent protein kinase enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells. J Biol Chem 278:8106-8111 (Pubitemid 36800551)
17. Chen WY, Juan LJ, Chung BC 2005 SF-1 (nuclear receptor 5A1) activity is activated by cyclic AMP via p300-mediated recruitment to active foci, acetylation, and increased DNA binding. Mol Cell Biol 25:10442-10453
18. Jacob AL, Lund J, Martinez P, Hedin L 2001 Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. J Biol Chem 276:37659-37664
19. Børud B, Hoang T, Bakke M, Jacob AL, Lund J, Mellgren G 2002 The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. Mol Endocrinol 16:757-773 (Pubitemid 34297745)
20. Dammer EB, Leon A, Sewer MB 2007 Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3′,5′-monophosphate-dependent cytochrome P450c17 transcription rate. Mol Endocrinol 21:415-438 (Pubitemid 46188282)
21. Li LA, Chiang EF, Chen JC, Hsu NC, Chen YJ, Chung BC 1999 Function of steroidogenic factor 1 domains in nuclear localization, transactivation, and interaction with transcription factor TFIIB and c-Jun. Mol Endocrinol 13:1588-1598 (Pubitemid 30650598)
22. Monté D, DeWitte F, Hum DW 1998 Regulation of the human P450scc gene by steroidogenic factor 1 is mediated by CBP/p300. J Biol Chem 273:4585-4591 (Pubitemid 28103201)
23. Zhou D, Quach KM, Yang C, Lee SY, Pohajdak B, Chen S 2000 PNRC: a proline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors including orphan receptors SF1 (steroidogenic factor 1) and ERRα1 (estrogen related receptor α-1). Mol Endocrinol 14:986-998 (Pubitemid 32250516)
24. Chen WY, Lee WC, Hsu NC, Huang F, Chung BC 2004 SUMO modification of repression domains modulates function of nuclear receptor 5A1 (steroidogenic factor-1). J Biol Chem 279:38730-38735 (Pubitemid 39296031)
25. Komatsu T, Mizusaki H, Mukai T, Ogawa H, Baba D, Shirakawa M, Hatakeyama S, Nakayama KI, Yamamoto H, Kikuchi A, Morohashi K 2004 Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol Endocrinol 18:2451-2462 (Pubitemid 39335980)
26. Campbell LA, Faivre EJ, Show MD, Ingraham JG, Flinders J, Gross JD, Ingraham HA 2008 Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1). Mol Cell Biol 28:7476-7486
27. Lee MB, Lebedeva LA, Suzawa M, Wadekar SA, Desclozeaux M, Ingraham HA 2005 The DEAD-box protein DP103 (Ddx20 or Gemin- 3) represses orphan nuclear receptor activity via SUMO modification. Mol Cell Biol 25:1879-1890 (Pubitemid 40280151)
28. Ogawa H, Komatsu T, Hiraoka Y, Morohashi K 2009 Transcriptional suppression by transient recruitment of ARIP4 to sumoylated nuclear receptor Ad4BP/SF-1. Mol Biol Cell 20:4235-4245
29. Shibata H, Ando T, Suzuki T, Kurihara I, Hayashi K, Hayashi M, Saito I, Kawabe H, Tsujioka M, Mural M, Saruta T 1998 Differential expression of an orphan receptor COUP-TFI and corepressors in adrenal tumors. Endocr Res 24:881-885 (Pubitemid 29016495)
30. Shibata H, Ando T, Suzuki T, Kurihara I, Hayashi K, Hayashi M, Saito I, Murai M, Saruta T 1998 COUP-TFI expression in human adrenocortical adenomas: possible role in steroidogenesis. J Clin Endocrinol Metab 83:4520-4523 (Pubitemid 29100161)
31. Shibata H, Ikeda Y, Mukai T, Morohashi K, Kurihara I, Ando T, Suzuki T, Kobayashi S, Murai M, Saito I, Saruta T 2001 Expression profiles of COUP-TF, DAX-1, and SF-1 in the human adrenal gland and adrenocortical tumors: possible implications in steroidogenesis. Mol Genet Metab 74:206-216
32. Shibata H, Kurihara I, Kobayashi S, Yokota K, Suda N, Saito I, Saruta T 2003 Regulation of differential COUP-TF-coregulator interactions in adrenal cortical steroidogenesis. J Steroid Biochem Mol Biol 85:449-456 (Pubitemid 37011121)
33. Kobayashi S, Shibata H, Kurihara I, Yokota K, Suda N, Saito I, Saruta T 2004 Ubc9 interacts with chicken ovalbumin upstream promoter-transcription factor I and represses receptor-dependent transcription. J Mol Endocrinol 32:69-86 (Pubitemid 38312622)
34. Kurihara I, Shibata H, Kobayashi S, Suda N, Ikeda Y, Yokota K, Murai A, Saito I, Rainey WE, Saruta T 2005 Ubc9 and Protein inhibitor of activated STAT 1 activate chicken ovalbumin upstream promoter-transcription factor I-mediated human CYP11B2 gene transcription. J Biol Chem 280:6721-6730 (Pubitemid 40341227)
35. Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE 2002 Differential regulation of aldosterone synthase and 11β-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 28:125-135 (Pubitemid 34428762)
36. Wang XL, Bassett M, Zhang Y, Yin S, Clyne C, White PC, Rainey WE 2000 Transcriptional regulation of human 11β-hydroxylase (hCYP11B1). Endocrinology 141:3587-3594
37. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE 1997 Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol 11:638-649 (Pubitemid 27193799)
38. Hanley NA, Rainey WE, Wilson DI, Ball SG, Parker KL 2001 Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. Mol Endocrinol 15:57-68
39. Hu MC, Chou SJ, Huang YY, Hsu NC, Li H, Chung BC 1999 Tissue-specific, hormonal, and developmental regulation of SCCLacZ expression in transgenic mice leads to adrenocortical zone characterization. Endocrinology 140:5609-5618 (Pubitemid 30645348)
40. Nogueira EF, Rainey WE 2010 Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members. Endocrinology 151:1060-1070
41. Yokota K, Shibata H, Kurihara I, Kobayashi S, Suda N, Murai- Takeda A, Saito I, Kitagawa H, Kato S, Saruta T, Itoh H 2007 Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9. J Biol Chem 282:1998-2010 (Pubitemid 47076701)
42. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266-3281
43. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM 2008 The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526-1540 (Pubitemid 351656485)
44. Lan HC, Li HJ, Lin G, Lai PY, Chung BC 2007 Cyclic AMP stimulates SF-1-dependent CYP11A1 expression through homeodomain- interacting protein kinase 3-mediated Jun N-terminal kinase and c-Jun phosphorylation. Mol Cell Biol 27:2027-2036 (Pubitemid 46418461)
45. Ye P, Nakamura Y, Lalli E, Rainey WE 2009 Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology 150:1303-1309
46. Sasano H, Shizawa S, Suzuki T, Takayama K, Fukaya T, Morohashi K, Nagura H 1995 Ad4BP in the human adrenal cortex and its disorders. J Clin Endocrinol Metab 80:2378-2380
47. Yang WH, Heaton JH, Brevig H, Mukherjee S, Iñiguez-Lluhi JA, Hammer GD 2009 SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation.MolCell Biol 29:613-625
48. Poukka H, Aarnisalo P, Karvonen U, Palvimo JJ, Jänne OA 1999 Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. J Biol Chem 274:19441-19446
49. Gross M, Yang R, Top I, Gasper C, Shuai K 2004 PIASy-mediated repression of the androgen receptor is independent of sumoylation. Oncogene 23:3059-3066 (Pubitemid 38648196)
50. Karpova T, Presley J, Manimaran RR, Scherrer SP, Tejada L, Peterson KR, Heckert LL 2005 A FTZ-F1-containing yeast artificial chromosome recapitulates expression of steroidogenic factor 1 in vivo. Mol Endocrinol 19:2549-2563 (Pubitemid 41362668)
51. Doghman M, Karpova T, Rodrigues GA, Arhatte M, De Moura J, Cavalli LR, Virolle V, Barbry P, Zambetti GP, Figueiredo BC, Heckert LL, Lalli E 2007 Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 21: 2968-2987 (Pubitemid 350223508)
52. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, Lichter P 2000 Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes Chromosomes Cancer 28:145-152 (Pubitemid 30246992)
53. Bassett MH, Mayhew B, Rehman K, White PC, Mantero F, Arnaldi G, Stewart PM, Bujalska I, Rainey WE 2005 Expression profiles for steroidogenic enzymes in adrenocortical disease. J Clin Endocrinol Metab 90:5446-5455 (Pubitemid 41262314)
54. Doghman M, Cazareth J, Douguet D, Madoux F, Hodder P, Lalli E 2009 Inhibition of adrenocortical carcinoma cell proliferation by steroidogenic factor-1 inverse agonists. J Clin Endocrinol Metab 94:2178-2183
55. Shibata H, Kobayashi S, Kurihara I, Saito I, Saruta T 2003 Nuclear receptors and co-regulators in adrenal tumors. Horm Res 59(Suppl 1):85-93 (Pubitemid 36173414)
56. Zhu S, Sachdeva M, Wu F, Lu Z, Mo YY 2010 Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene 29:1763-1772
57. Coppola D, Parikh V, Boulware D, Blanck G, Ogata Y, Osaki T, Naka T, Iwahori K, Furukawa M, Nagatomo I, Kijima T, Kumagai T, Yoshida M, Tachibana I, Kawase I 2009 Substantially reduced expression of PIAS1 is associated with colon cancer development overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation. J Cancer Res Clin Oncol 135:1287-1291
58. Ogata Y, Osaki T, Naka T, Iwahori K, Furukawa M, Nagatomo I, Kijima T, Kumagai T, Yoshida M, Tachibana I, Kawase I 2006 Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation. Neoplasia 8:817-825 (Pubitemid 44564837)